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I N T R O D U C T I O N
In the airways and lungs, nitric oxide (NO) is produced 
by epithelial ciliated cells, type II alveolar cells, and neu-
ral fibers that innervate the airway smooth muscle cells 
(SMCs) (Ricciardolo et al., 2004). It has been suggested 
that the NO released by these cells decreases airway resis-
tance and that NO, released by neural fibers, is a major 
nonadrenergic,  noncholinergic  neurotransmitter  re-
sponsible for airway SMC relaxation (Belvisi et al., 1995). 
In addition, airway inflammation is associated with a 
considerable increase in NO synthesis by inflammatory 
cells, including macrophages, mast cells, and neutrophils. 
However, in asthma, airway inflammation is accompa-
nied by airway hyperresponsiveness, a behavior charac-
terized by increased airway contraction in response to a 
variety of stimuli that suggests an impediment of the air-
ways to relax in response to NO and other natural or 
pharmacological bronchodilators (Ricciardolo et al., 
2004). The mechanisms responsible for these asthma-
associated changes are still not completely understood.
Correspondence to Michael J. Sanderson: 
Michael.Sanderson@ﾭumassmed.edu
Abbreviations used in this paper: 5-HT, 5-hydroxytryptamine; IP3, 
inositol  trisphosphate;  IP3R,  IP3  receptor;  ISO,  isoproterenol;  MLCK, 
myosin  light  chain  kinase;  MLCP,  myosin  light  chain  phosphatase;   
NO, nitric oxide; PDE, phosphodiesterase; ROI, region(s) of interest; SE, 
standard error; sGC, soluble guanylate cyclase; SMC, smooth muscle cell; 
ZAP, zaprinast.
A first step toward understanding how asthma and 
other obstructive lung diseases alter airway responsive-
ness is to elucidate the cellular mechanisms regulating 
changes in airway resistance induced by agonists and 
NO in healthy individuals. The small intrapulmonary 
airways are considered a major site for this regulation; 
however, the contractile responses of the SMCs of these 
airways are relatively unexplored because they are diffi-
cult  to  isolate  and  study  with  conventional  methods 
used to measure cell signaling and/or force develop-
ment. Consequently, we have adopted a novel approach 
that combines the use of mouse lung slices and confocal 
microscopy to simultaneously evaluate Ca
2+ signaling 
in SMCs and airway contraction. With this approach, we 
previously emphasized that agonist-induced airway con-
traction is regulated by two intracellular processes or 
signals (Sanderson et al., 2008). These are (a) the fre-
quency of agonist-induced oscillations in [Ca
2+]i, referred 
to as Ca
2+ oscillations (Perez and Sanderson, 2005) (a 
Ca
2+-dependent mechanism), and (b) the magnitude of 
an agonist-induced increase in the sensitivity of the con-
tractile machinery to [Ca
2+]i, referred to as Ca
2+ sensitiv-
ity  (Bai  and  Sanderson,  2006b)  (a  Ca
2+-independent 
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Nitric oxide (NO) induces airway smooth muscle cell (SMC) relaxation, but the underlying mechanism is not well 
understood. Consequently, we investigated the effects of NO on airway SMC contraction, Ca
2+ signaling, and Ca
2+ 
sensitivity in mouse lung slices with phase-contrast and confocal microscopy. Airways that were contracted in re-
sponse to the agonist 5-hydroxytryptamine (5-HT) transiently relaxed in response to the NO donor, NOC-5. This 
NO-induced relaxation was enhanced by zaprinast or vardenafil, two selective inhibitors of cGMP-specific phos-
phodiesterase-5, but blocked by ODQ, an inhibitor of soluble guanylyl cyclase, and by Rp-8-pCPT-cGMPS, an inhib-
itor of protein kinase G (PKG). Simultaneous measurements of airway caliber and SMC [Ca
2+]i revealed that airway 
contraction induced by 5-HT correlated with the occurrence of Ca
2+ oscillations in the airway SMCs. Airway relax-
ation induced by NOC-5 was accompanied by a decrease in the frequency of these Ca
2+ oscillations. The cGMP ana-
logues and selective PKG activators 8Br-cGMP and 8pCPT-cGMP also induced airway relaxation and decreased the 
frequency of the Ca
2+ oscillations. NOC-5 inhibited the increase of [Ca
2+]i and contraction induced by the photo-
lytic release of inositol 1,4,5-trisphosphate (IP3) in airway SMCs. The effect of NO on the Ca
2+ sensitivity of the air-
way SMCs was examined in lung slices permeabilized to Ca
2+ by treatment with caffeine and ryanodine. Neither 
NOC-5 nor 8pCPT-cGMP induced relaxation in agonist-contracted Ca
2+-permeabilized airways. Consequently, we 
conclude that NO, acting via the cGMP–PKG pathway, induced airway SMC relaxation by predominately inhibiting 
the release of Ca
2+ via the IP3 receptor to decrease the frequency of agonist-induced Ca
2+ oscillations.
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thio)-guanosine-3,5-cyclic monophosphorothioate·Na (Rp-8- 
pCPT-cGMPS)  and  cell-permeant  caged  IP3  (caged  IP3-PM;   
d-2,3-O-isopropylidene-6-O-(2-nitro-4,5-dimethoxy)benzyl-myo-inositol- 
1,4,5-trisphosphate-hexakis (propionoxymethyl) ester) was obtained 
from Enzo Life Sciences, Inc. 8Br-cGMP and 8-(4-chlorophenyl-
thio)guanosine-3, 5-cyclic monophosphate (8pCPT-cGMP) were 
obtained from Sigma-Aldrich. Hanks’ balanced salt solution was 
supplemented with 20 mM HEPES buffer and adjusted to pH 7.4 
(sHBSS). Vardenafil HCl (Levitra) was provided by GlaxoSmith-
Kline and Bayer HealthCare. Stock solutions of vardenafil and 
ZAP were prepared at 10 mM in DMSO. Vardenafil was prepared 
on the same day of use, whereas ZAP was stored at 20°C. Varde-
nafil and ZAP were diluted to the final concentration in sHBSS   
on the same day of use. NOC-5 was dissolved in 0.1 N NaOH to 
prepare a 100-mM stock solution. Aliquots of this solution were 
stored at 20°C for up to 3 mo. SNAP was dissolved in DMSO to 
prepare a 100-mM stock solution. NO is not released from NOC-5 
or SNAP in the stock solution at alkaline pH. NOC-5 was diluted 
to the final concentration in sHBSS within 15 min of the initiation 
of each experiment. The release of NO from NOC-5 and SNAP 
only begins when stock solutions are diluted in sHBSS and the pH 
is neutralized. The rates of release are different for each donor; 
the half-life (t1/2, time to release 50% of NO) of NO release from 
NOC-5 and SNAP at pH 7.4, 22°C is 93 and 600 min, respectively 
(NOC-5 and SNAP data sheets; EMD). Each molecule of SNAP   
or NOC-5 releases one or two NO equivalents, respectively. We 
have calculated that 2 µM NO will be dissolved in the sHBSS at 
15 min after diluting to 10 µM NOC-5.
Lung slices
The methods used to prepare lung slices have been described in 
detail (Perez and Sanderson, 2005; Perez-Zoghbi and Sanderson, 
2007), and only a brief outline is given. Lung slices were prepared 
from 7–10-wk-old BALB/c mice. The trachea was cannulated, and 
after opening the chest cavity, the lungs were inflated with 1.3 ± 
0.1 ml of 2% agarose (low-gelling temperature) in sHBSS, fol-
lowed by 0.2 ml of air to flush the agarose-sHBSS out of the air-
ways and into the distal alveolar space. The agarose was gelled by 
cooling the lungs with cold sHBSS. A single lung lobe was re-
moved and cut into serial sections of 130-µm thick with a vibra-
tome at 4°C. Slices were maintained in DMEM at 37°C and 10% 
CO2.  Serum  was  not  used  because  it  contains  growth  factors 
(Abdullah et al., 1994). We used lung slices maintained for fewer 
than 48 h; no significant changes in airway contractility in re-
sponse to 1 µM 5-hydroxytryptamine (5-HT) were detected dur-
ing this period.
Measurement of the contractile response of airways
Lung slices were placed on a large cover glass, mounted in a custom-
made perfusion chamber, and held in place with a small sheet of 
nylon mesh. A second cover glass, edged with silicone grease, was 
placed over the nylon mesh and lung slice. Perfusion of the lung 
slice within the chamber was maintained at a constant rate during 
the course of the experiments by a gravity-fed perfusion system. 
The volume of the chamber was 100 µl with a perfusion rate of 
800 µl/min. The addition and washout of agonists, NO, and 
drugs were achieved by changing the perfusion solution with a 
custom-made, computer-controlled valve system. This setup al-
lows multiple challenges of the lung slice with different stimuli 
without undesired movements of the slice, yet allowing the air-
ways to contract and relax. For phase-contrast microscopy, lung 
slices were observed with an inverted microscope with a 10× ob-
jective, and images were recorded in time-lapse (30 frames/min) 
using a CCD camera and image acquisition software (Video Sa-
vant; IO Industries). The area of the airway lumen was calculated 
from each image by pixel summing using custom-written software. 
Experiments were performed at room temperature.
mechanism). In addition, the relaxation of airway SMCs 
induced by the activation of 2 adrenergic receptors with 
isoproterenol (ISO), albuterol, or formoterol was shown 
to be accompanied by both a cAMP-dependent decrease 
in the frequency of Ca
2+ oscillations and a decrease in 
Ca
2+ sensitivity (Bai and Sanderson, 2006a; Delmotte and 
Sanderson, 2008, 2009; Ressmeyer et al., 2009). Here, we 
extended these studies to investigate the mechanisms re-
sponsible for airway relaxation induced by NO.
The signaling cascade by which NO induces SMC relax-
ation has been mainly studied in vascular SMCs of the sys-
temic circulation. In these blood vessels, NO is synthesized 
in the endothelial cells and diffuses to the adjacent SMCs, 
where it activates soluble guanylate cyclase (sGC) to syn-
thesize cGMP. This cGMP acts as a second messenger 
to activate cGMP-dependent PKG and/or other effector 
proteins, including ion channels, ion pumps, and phos-
phodiesterases (PDEs) (Carvajal et al., 2000). The phos-
phorylation  of  one  or  more  target  molecules  by  PKG 
and/or a direct activation/inhibition of ion channels by 
cGMP are believed to lead to SMC relaxation.
However, the details of the mechanism by which an 
increase in cGMP results in SMC relaxation are often 
controversial and can vary considerably, and the pre-
cise  mechanism  occurring  in  the  small  pulmonary 
airways is unknown. For example, the contribution of 
Ca
2+-dependent and Ca
2+-independent pathways to SMC 
relaxation can differ with the location of the blood vessels 
(Chitaley and Webb, 2002; Kitazawa et al., 2009). Further-
more, many of the regulatory proteins participating in 
these pathways have been shown to be affected by cGMP 
or PKG. In addition, cGMP/PKG-independent mecha-
nisms for NO-induced SMC relaxation have been pro-
posed (Janssen et al., 2000; Soloviev et al., 2004).
We hypothesized that, in small airway SMCs, NO acti-
vates a cGMP/PKG-dependent pathway to decrease the 
frequency of agonist-induced Ca
2+ oscillations and/or the 
Ca
2+ sensitivity of the contractile machinery to induce air-
way relaxation. To test this hypothesis, we examined the 
effects of NO on agonist-induced airway contractility and 
the associated Ca
2+ oscillations and Ca
2+ sensitivity of the 
airway SMCs in mouse lung slices. We found that NO me-
diated a cGMP-dependent reduction of the frequency of 
the agonist-induced Ca
2+ oscillations, and that this inhibi-
tory effect was the result of a reduced Ca
2+ mobilization 
via the inositol trisphosphate (IP3) receptor (IP3R) from 
internal Ca
2+ stores. However, NO had a minimal effect 
on the Ca
2+ sensitivity of the contractile machinery.
M AT E R I A L S   A N D   M E T H O D S
General reagents were obtained either from Life Technologies or 
Sigma-Aldrich. 3-[2-hydroxy-1-(1-methylethyl)-2-nitrosohydrazino]-1- 
propanamine  (NOC-5),  S-nitroso-N-acetylpenicillamine  (SNAP),   
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), and zaprinast 
(ZAP) were obtained from EMD. Ryanodine (free of dehydro- 
ryanodine) was obtained from Invitrogen. Rp-8-(4-chlorophenyl-  Perez-Zoghbi et al. 249
Measurements of intracellular Ca
2+
Approximately  10–12  lung  slices  were  incubated  in  2  ml  of   
20 µM Oregon Green 488 BAPTA-1-AM (Invitrogen), 100 µM sulfo-
bromophthalein (an inhibitor temporarily used to prevent dye 
extrusion through anion exchangers; Sigma-Aldrich), and 0.2% 
Pluronic F-127 (Invitrogen) for 50 min at 30°C, followed by an 
additional 50 min at 30°C in sHBSS containing 100 µM sulfobromo-
phthalein. Lung slices were mounted in the perfusion chamber as 
described. Fluorescence imaging was performed using a video-
rate confocal microscope (Sanderson and Parker, 2003). A 488-nm 
laser supplied the excitation wavelength, and the resultant fluores-
cence images (>510 nm) were recorded at 15 Hz. Changes in fluores-
cence intensity were analyzed by selecting regions of interest 
(ROI) ranging from 5 to 7 pixels
2. The average fluorescence 
intensities of an ROI were obtained, frame by frame, using cus-
tom-written software that allowed the tracking of the ROI within 
an SMC as it moved with contraction. Final fluorescence values 
(F) were expressed as a fluorescence ratio (F/F0) normalized to 
the initial fluorescence (F0). Line scan analysis of images was per-
formed by extracting a line of pixels from each image and placing 
them sequentially to form a time sequence in a single image.
Flash photolysis of caged IP3
Flash photolysis of caged IP3 was used to experimentally increase 
the [IP3]i. Lung slices were initially loaded with Oregon Green 
488 BAPTA-1 AM as described above. Subsequently, slices were in-
cubated at room temperature with 2 µM of caged IP3-PM (for 1 h) 
in  sHBSS  containing  0.1%  pluronic  and  100  µM  sulfobromo-
phthalein, followed by de-esterification for 30 min in sHBSS con-
taining 100 µM sulfobromophthalein. The details of the flash 
photolysis setup have been described (Leybaert and Sanderson, 
2001; Bai and Sanderson, 2006a). In brief, a flash of UV light was 
produced from a mercury arc lamp with a mechanical shutter and 
focused into the microscope with a biconvex lens (focal distance, 
200 mm) through a band-pass filter (330 nm). Flash duration and 
intensity were controlled by electronic timing and neutral density 
filters, respectively. The area illuminated was adjusted with an iris 
diaphragm at a conjugate image plane.
Preparation of Ca
2+-permeabilized lung slices
To clamp the [Ca
2+]i of airway SMCs, the lung slices were made 
permeable to external Ca
2+ without using detergents or toxins. 
This approach does not damage the cell membrane and exploits 
the cell’s inherent Ca
2+-permeable ion channels. Lung slices were 
exposed to 20 mM caffeine with 50 µM ryanodine for 4 min, 
followed by a washout with sHBSS. This treatment locks the RYRs 
in the SR of airway SMCs in an open state that depletes the intra-
cellular Ca
2+ stores. This, in turn, increases Ca
2+ influx via store-
operated channels across the plasma membrane. Full details and 
Figure 1.  Airway relaxation induced by NO donors and its en-
hancement by ZAP. (A) Phase-contrast images showing the ap-
pearance of an airway in a lung slice (1) at rest, (2) after 8 min 
of stimulation with 0.1 µM 5-HT, (3) after relaxation induced by 
10 µM NOC-5, and (4) after further relaxation induced by NOC-5 
in the presence of 10 µM ZAP (image times indicated by arrows 
in B). (B, black trace) The change in the cross-sectional area of 
the lumen of an airway with respect to time showing the contrac-
tion in response to 5-HT and subsequent relaxation induced by 
NOC-5 in the absence or presence of ZAP (top bars). The air-
way contracted in response to 5-HT and relaxed in response to 
NOC-5. The effect of NOC-5 was biphasic and quickly reversed 
upon NOC-5 washout. ZAP alone had little effect on airway con-
traction but increased the relaxing effect of NOC-5. The effect of 
ZAP was reversed after washout. (B, gray trace) The relaxation 
of 5-HT–contracted airways induced by 50 µM SNAP. (C) Con-
centration dependence of airway relaxation induced by NOC-5 
in the absence (black traces) or presence (gray traces) of ZAP. 
Relaxation was measured as the increase in lumen area after 30 s 
(peak; dashed lines, circles) or after 10 min (sustained; continu-
ous lines, squares) of NOC-5 exposure from experiments shown 
in B. In control experiments with 5-HT alone (not depicted), we 
observed a slow but continued increase in airway contraction of 
2.1 ± 1.3 and 1.6 ± 1.1% during the time periods of 12–22 min and 
48–58 min, which correspond to the exposure times for NOC-5 
or NOC-5/ZAP. Consequently, we corrected the measurements 
of sustained relaxation at these times by adding the correspond-
ing additional contraction. Each point represents the mean ± SE 
from at least five different slices from at least two mice. A movie 
of these data is shown in Video 1.
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for SNAP and t1/2 = 93 min for NOC-5). These results 
suggest that airway relaxation is induced by NO in a 
manner that is unrelated to the chemical nature of 
the donor molecule.
Because NO is believed to act via increases in cGMP, 
we examined the effect of reducing the rate of cGMP 
metabolism with the PDE-5–selective inhibitor ZAP on 
the airway response to NO. The addition of 10 µM ZAP 
alone to airways contracted with 5-HT had only a small 
transient relaxing effect (3.2 ± 1.8%; n = 7 of the maxi-
mal contraction). However, the presence of ZAP signifi-
cantly  increased  the  sustained  relaxation  induced  by 
the subsequent addition of NOC-5 (Fig. 1 B and Table I); 
ZAP had no significant effect on the peak relaxation   
induced by NOC-5 (Table I). The removal of ZAP, by 
washing with sHBSS containing 5-HT and NOC-5, in-
duced a slow airway recontraction, indicating a revers-
ibility  of  the  effects  of  ZAP.  Subsequent  removal  of 
NOC-5 resulted in a further airway contraction to reach 
the original contracted state.
The extent of airway relaxation induced by NOC-5 
increased with the concentration of NOC-5 from 0.5 to 
10 µM in both the absence and presence of 10 µM ZAP 
(Fig. 1 C). In the absence of ZAP, the peak relaxation 
was significantly greater than the sustained airway relax-
ation at all NOC-5 concentrations. However, in the pres-
ence of ZAP, the peak and sustained airway relaxation 
were similar. These results suggest that PDE-5 activity in 
airway SMCs normally reduces the cGMP levels to miti-
gate the effects of NO.
In airways contracted with 1 µM ACh, a similar effect 
of NOC-5 and ZAP on peak and sustained relaxation 
was observed (Table I), indicating that the relaxing 
effect of NOC-5 and ZAP was not specific to 5-HT. In 
addition, 1 µM vardenafil, a clinically approved PDE-5 
inhibitor,  had  a  similar  effect  as  ZAP  and  enhanced 
validation  for  this  technique  have  been  reported  (Bai  and 
Sanderson, 2006b). In caffeine-ryanodine–treated lung slices, the 
[Ca
2+]i of airway SMCs is dependent on the extracellular Ca
2+ con-
centration ([Ca
2+]e). By exposing the lung slices to sHBSS con-
taining 1.3 mM Ca
2+, the [Ca
2+]i was clamped at a sustained high 
level. In all experiments, the [Ca
2+]i was examined by confocal 
microscopy and was confirmed not to change during the addition 
of experimental compounds.
Statistic values are expressed as mean ± standard error (SE). 
A Student’s t test was used to test for significant differences be-
tween means.
Online supplemental material
Three videos consisting of sequences of phase-contrast or confo-
cal fluorescence images were produced with Video Savant (IO In-
dustries). The playback rate of 30 fps represents an increased 
time factor of ×15. Videos 1–3 are available at http://www.jgp 
.org/cgi/content/full/jgp.200910365/DC1.
R E S U LT S
Airway relaxation induced by NO
To study the effect of NO on airway contraction, we ini-
tially stimulated lung slices with the agonist 5-HT at a 
concentration that produced a submaximal airway con-
traction (Fig. 1 and Video 1). The addition of 0.1 µM   
5-HT induced a fast airway contraction with a reduction 
in the airway lumen area of 60 ± 9% (mean ± SE; Fig. 1). 
The subsequent addition of 10 µM NOC-5, an NO do-
nor, induced a biphasic airway relaxation consisting of 
an initial peak, followed by a partial recontraction to a 
lower level of sustained relaxation (Fig. 1 B and Table I). 
The effect of NOC-5 was quickly reversed upon its   
removal; the airway recontracted to the initial 5-HT–
induced contractile state. A similar airway relaxation 
(Fig. 1 B and Table I) was observed in response to   
50  µM  SNAP,  another  NO  donor  with  a  different 
chemical structure and longer lifetime (t1/2 = 600 min 
TA B L e   I
Airway relaxation induced by NOC-5 and its modulation by related compounds
Experimental conditions Relaxation (% of maximal contraction)
Peak Sustained n
5-HT–contracted airways
NOC-5 (10 µM) 44 ± 6 12 ± 3 7
SNAP (50 µM) 49 ± 12 17 ± 9 3
NOC-5 + ZAP (10 µM) 49 ± 8 46 ± 6
b 7
NOC-5 + ODQ (5 µM) 4 ± 2
a 2 ± 1
b 6
NOC-5 + Rp-8-pCPT-cGMPS (20 µM) 5 ± 3
a 3 ± 2
b 5
ACH-contracted airways
NOC-5 (10 µM) 40 ± 7 11 ± 6 3
NOC-5 + ZAP (10 µM) 46.4 ± 8.7 45.7 ± 7.9
b 3
NOC-5 + VAR (1 µM) 53.1 ± 9.8 52.3 ± 9.2
b 5
PDE-5 inhibitors: ZAP and vardenifil (VAR); sGC inhibitor (ODQ); PKG inhibitor (Rp-8-pCPT-cGMPS). The peak and sustained relaxation of airways 
in response to NOC-5 in the absence or presence of ZAP, ODQ, and Rp-8-pCPT-cGMPS calculated from experiments similar to those shown in Figs. 2 
and 3.
aP < 0.05 compared to peak relaxation induced by NOC-5 alone.
bP < 0.05 compared to sustained relaxation induced by NOC-5 alone.  Perez-Zoghbi et al. 251
which the Ca
2+ oscillations reappeared but at much slower 
frequencies (1.5 ± 0.4 cycles/min; n = 4 SMCs from two 
slices). These low frequency Ca
2+ oscillations continued 
to form Ca
2+ waves, but with a longer duration of ele-
vated Ca
2+ (Fig. 3 C, line scan) and an increased ampli-
tude (F/F0 = 0.5 ± 0.1 and 0.8 ± 0.2 before and after 
NOC-5, respectively) (Fig. 3 C) as compared with those 
observed in the absence of ZAP. The longer Ca
2+ oscilla-
tion period may allow for a greater accumulation of 
Ca
2+ in the SR to be available for subsequent release. 
The greater reduction in the frequency of the Ca
2+ oscilla-
tions induced by NOC-5 in the presence of ZAP also cor-
related with a greater relaxation of the airway (Fig. 1 B), 
suggesting that NO induced airway relaxation by reduc-
ing the frequency of the Ca
2+ oscillations.
NOC-5–induced sustained airway relaxation from 11.5 ± 
3.7% in the absence of vardenafil to 52.3 ± 9.2% in the 
presence of vardenafil (five experiments from three dif-
ferent slices). These data suggest that ZAP and vardenafil 
increased NOC-5–induced airway relaxation by inhibit-
ing cGMP-specific PDE activity.
Effect of sGC and PKG inhibitors on NO-induced  
airway relaxation
To evaluate if airway relaxation was dependent on cGMP 
synthesis by NO-activated sGC, we examined the effect 
of ODQ, a selective inhibitor of sGC, on NO-induced 
airway relaxation. We found that airway relaxation in-
duced  by  NOC-5  was  significantly  inhibited  by  ODQ 
(Fig. 2 A and Table I).
Because these results suggest that NO-induced airway 
relaxation occurs through a cGMP-dependent mecha-
nism, we further investigated whether NO-induced re-
laxation requires the activation of PKG by examining 
the effects of Rp-8-pCPT-cGMPS, a selective PKG inhibi-
tor. At low concentrations (1 µM), Rp-8-pCPT-cGMPS 
had no significant effect on NOC-5–induced relaxation 
(five slices from two mice). However, at higher concen-
trations  (20  µM),  we  found  that  Rp-8-pCPT-cGMPS 
strongly  inhibited  the  relaxation  induced  by  NOC-5 
(Fig. 2 B and Table I). This concentration of Rp-8-pCPT-
cGMPS required to inactivate PKG is similar to the 
concentration  of  8-pCPT-cGMP  required  to  activate 
PKG (see below). These results suggest that a cGMP-
dependent activation of PKG is required for NO-induced 
airway relaxation.
Effect of NO on SMC Ca
2+ signaling
We next examined the effect of NO on 5-HT–induced 
Ca
2+ signaling of airway SMCs. In response to 5-HT, 
airway SMCs displayed an increase in [Ca
2+]i, followed 
by sustained Ca
2+ oscillations (mean frequency, 25.0 ± 
6.5 cycles/min; n = 5 SMCs from three slices) that 
spread  throughout  the  SMCs  as  intracellular  Ca
2+ 
waves (Fig. 3, A and B, and Video 2). The subsequent 
addition of NOC-5 resulted in a cessation of the Ca
2+ 
oscillations for 1 min. This inhibition of the Ca
2+ 
signaling correlated with the relaxation of the airway 
induced by NOC-5 (Video 2 and Fig. 1). With time, in 
the continued presence of NOC-5 and 5-HT, the Ca
2+ 
oscillations resumed and slowly increased their fre-
quency to reach a new steady rate, but at a lower fre-
quency (8.0 ± 3.3 cycles/min; n = 5 SMCs from three 
slices) than the frequency with 5-HT alone (Fig. 3 B). 
This  resumption  of  the  Ca
2+  oscillations  correlated 
with the partial recontraction of the airway (Fig. 1).
Although ZAP alone had little or no effect on the 
Ca
2+ oscillations induced by 5-HT, ZAP significantly in-
creased the inhibitory action of NOC-5 on Ca
2+ oscillations 
(Fig. 3 C). In the presence of ZAP, NOC-5 stopped the 
Ca
2+ oscillations for longer periods (up to 2 min), after 
Figure 2.  The attenuation of NO-induced airway relaxation by 
inhibitors of sGC and PKG activity. (A) The effect of 5 µM ODQ, 
a sGC inhibitor, on airway relaxation induced by NOC-5. The air-
way, contracted with 5-HT, relaxed in response to NOC-5 in the 
absence but not in the presence of ODQ. (B) The effect of 20 µM 
Rp-8-pCPT-cGMPS, a PKG inhibitor, on airway relaxation induced 
by NOC-5. Airway relaxation induced by NOC-5 was reduced by 
Rp-8-pCPT-cGMPS. Representative experiments selected from at 
least five different slices from three mice are shown.252 NO-induced relaxation and Ca
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NOC-5 are mediated through the NO-induced activa-
tion of sGC.
Effect of 8pCPT-cGMP and 8Br-cGMP on airway 
contraction and Ca
2+ signaling
To support the idea that NOC-5 effects were mediated 
by an increase in cGMP concentration, we studied the 
effect of the cGMP analogues 8pCPT-cGMP and 8Br-
cGMP on the contraction and Ca
2+ signaling of airway 
SMCs (Fig. 4). These cGMP analogues are permeable 
to cell membranes, resistant to hydrolysis by PDEs, and 
selective activators of PKG. Increasing concentrations 
of  8pCPT-cGMP  and  8Br-cGMP  induced  increasing 
To investigate whether the inhibitory effect of NOC-5 
on Ca
2+ oscillations was dependent on the activation of 
sGC by NO, we examined the effects of ODQ on NOC-5 
inhibition of 5-HT–induced Ca
2+ signaling (Fig. 3 D). 
ODQ alone had no significant effect on the frequency 
of Ca
2+ oscillations (27.5 ± 1.9 and 26.4 ± 2.3 cycles/
min before and 2 min after the addition of ODQ, re-
spectively; n = 5 SMCs from three slices; P > 0.05). 
However,  ODQ  completely  blocked  the  ability  of 
NOC-5 to inhibit Ca
2+ oscillations; the Ca
2+ oscillation 
frequency was 25.2 ± 2.8 and 27.7 ± 1.5 cycles/min at 1 
and 4 min after NOC-5 addition, respectively. These 
results are consistent with the idea that the effects of 
Figure 3.  The effect of NOC-5, ZAP, and ODQ on the Ca
2+ signaling induced by 5-HT in airway SMCs. (A) A fluorescence confocal 
image of part of an airway in a lung slice showing the epithelial cells (EPCs) lining the airway lumen and the underlying SMCs. (B, top 
trace) Ca
2+ changes in a small region (7 × 7 pixels, indicated by the white square in A) within an SMC plotted as a ratio (F/F0) with 
respect to time showing the effect of 10 µM NOC-5 on the Ca
2+ oscillations induced by 0.1 µM 5-HT. In the bottom part of B, a line 
scan analysis from the longitudinal axis of the SMC (indicated by the dashed line in A) shows the propagation of the Ca
2+ oscillations 
along the SMC as Ca
2+ waves (near vertical white lines). The position of both the ROI and the line scan was adjusted to track the same 
area inside the SMC during airway contraction. NOC-5 transiently blocked the Ca
2+ oscillations, which resumed with a lower frequency. 
(C and D) Ca
2+ traces and line scan showing the effect of 10 µM ZAP and 5 µM ODQ on the Ca
2+ oscillations induced by 0.1 µM 5-HT 
and subsequent inhibition by 10 µM NOC-5 in single SMCs. ZAP or ODQ alone had no effect on the Ca
2+ oscillations induced by 5-HT. 
However, in the presence of ZAP, NOC-5 further decreased the frequency and increased the amplitude and duration of the Ca
2+ waves 
(line scan: lines brighter and wider, respectively). In contrast, ODQ blocked the inhibitory action of NOC-5 on the Ca
2+ oscillations. 
Representative data from at least seven different slices from three mice are shown. A movie of the effect of NOC-5 on 5-HT–induced Ca
2+ 
signaling in airway SMCs is shown in Video 2.  Perez-Zoghbi et al. 253
slow diffusion of the analogues through the plasma 
membrane and their high resistance to degradation   
by PDEs.
In keeping with the reduction of the Ca
2+ oscillation 
frequency by NOC-5, these cGMP analogues gradu-
ally reduced the frequency of the 5-HT–induced Ca
2+ 
oscillations until they almost completely stopped (with 
8pCPT-cGMP) or attained a new slower steady frequency 
relaxation of 5-HT–contracted airways (Fig. 4, A and B). 
However,  8pCPT-cGMP  induced  a  greater  maximal 
relaxation than 8Br-cGMP (Fig. 4 C). Compared with 
NOC-5,  the  cGMP  analogues  induced  airway  relax-
ation  in  a  slower  but  more  sustained  manner  that   
persisted longer after washout of 8pCPT-cGMP or 8Br-
cGMP (Figs. 1 B and 4). This slow relaxation kinetics 
associated with cGMP analogues is consistent with the 
Figure 4.  Airway relaxation and inhibition of Ca
2+ oscillations induced by cGMP analogues. (A and B) Airways contracted with 0.1 µM 
5-HT were induced to relax by increasing concentrations (top bars) of (A) 8pCPT-cGMP or (B) 8Br-cGMP. Airways either recontracted 
slightly or remained relaxed after washout of 8pCPT-cGMP or 8Br-cGMP for 5 min. (C) Concentration–airway relaxation response in-
duced by 8pCPT-cGMP (black line) and 8Br-cGMP (gray line). Relaxation was measured as the increase in the lumen area after 8 min of 
the addition of cGMP analogues and normalized to the airway contraction before the addition of the cGMP analogue (data points are 
mean ± SE from four slices from two mice). (D and E) The effect of either 50 µM 8pCPT-cGMP or 8-Br-cGMP on the Ca
2+ oscillations 
induced by 0.1 µM 5-HT. 8pCPT-cGMP and 8Br-cGMP reduced the frequency of the Ca
2+ oscillations induced by 5-HT. (F) Summary of 
the effect of cGMP analogues on the frequency of Ca
2+ oscillations measured before (control) and after the addition of cGMP analogues 
(n = 5 SMCs from different slices from three mice; *, P < 0.05).254 NO-induced relaxation and Ca
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(with 8Br-cGMP) (Fig. 4 D, E and F). These results sug-
gest that increases in cGMP concentration induce airway 
relaxation by reducing the frequency of agonist-induced 
Ca
2+ oscillations.
Effect of NO on intracellular Ca
2+ release
To investigate the mechanism by which NO inhibits Ca
2+ 
oscillations, we studied the effect of NOC-5 on the release 
of Ca
2+ from internal Ca
2+ stores via the IP3R by the pho-
tolytic release of IP3 from caged IP3 (Fig. 5). In the ab-
sence of NOC-5, the photolysis of caged IP3 in a limited 
area within the SMC (Fig. 5 A, circle) triggered an in-
stantaneous increase in [Ca
2+]i in the illuminated area 
that resulted in a propagating increase in [Ca
2+]i along 
the longitudinal axes of the SMC and a local airway con-
traction (Video 3). The increase in [Ca
2+]i was observed 
in a selected ROI adjacent to the flash area (Fig. 5 B, top 
trace) and throughout the length of the SMC by a line 
scan analysis (Fig. 5 B). Because the flash was restricted 
to the center of the cell, the increase in fluorescence at 
the ROI and along the whole cell (bright white line) in-
dicates the Ca
2+ increase spread out as a wave from the 
point of illumination. This is illustrated by Video 3. This 
Ca
2+ wave was accompanied by a transient contraction 
of the SMC and reduction of the airway lumen area 
(Fig. 5 B, bottom trace). A second flash exposure a min-
ute later to release IP3 again in the same area stimulated 
a similar Ca
2+ and contractile response. However, in the 
presence of NOC-5, a third and fourth flash photolysis 
of caged IP3 triggered neither a Ca
2+ nor contractile re-
sponse. The subsequent removal of NOC-5 by washing 
with sHBSS alone restored the ability of flash photo-
lysis to trigger a Ca
2+ and contractile response (Fig. 5 B). 
The flash exposure of SMCs not loaded with caged IP3 
had no effect on Ca
2+ release or contraction, suggesting 
that the SMC responses to UV flashes described above 
were dependent on the uncaging of IP3 and not an arti-
fact of the UV flash. In other control experiments, the 
SMCs responded similarly to six sequential flash expo-
sures, confirming that the quantity of caged IP3 was not 
a limiting factor. A longer UV flash induced Ca
2+ oscilla-
tions (Bai et al., 2009) but depleted the caged IP3 to 
prevent multiple responses.
These results indicate that NO inhibited IP3-induced 
release of Ca
2+ from the SR via the IP3R. However, these 
results do not rule out the possibility that the internal 
Figure 5.  The effect of NOC-5 on the release of Ca
2+ through 
IP3Rs. (A) Fluorescence image of part of an airway indicating the 
area (white circle) within an SMC exposed to light to uncage IP3, 
the ROI (white square) used to determine the changes in [Ca
2+]i 
with respect to time and the row of pixels (dashed line) used for 
line scan analysis plotted in B. The position of both the ROI and 
the line scan were adjusted to track the same area inside the 
SMC  during  airway  contraction.  (B)  Simultaneous  changes  in 
Ca
2+ signaling (top traces and line scans) and contraction (bottom 
traces) triggered by uncaging IP3 with UV flashes (arrows) in the 
absence or presence of 10 µM NOC-5 (top bar). The airway was al-
lowed to relax completely between challenges with UV flashes to 
assure that the same area within the SMC was illuminated. In the 
absence of NOC-5, each UV flash triggered a transient increase in 
[Ca
2+]i (trace) that was initiated in the flash area and propagated 
along the SMC as a Ca
2+ wave (white vertical line in line scan). 
The Ca
2+ wave was accompanied by a transient airway contraction   
(bottom). Perfusion with NOC-5 (top bar) blocked the Ca
2+ tran-
sient and the contraction triggered by releasing IP3. Representa-
tive data from seven different slices from two mice are shown.   
(C) Ca
2+ signaling in airway SMCs and airway contraction stimulated 
by 20 mM caffeine in the absence or presence of 10 µM NOC-5 
(top bars). NOC-5 had no apparent effect on the Ca
2+ signal and 
contraction induced by caffeine. Representative data from four 
different slices from two mice are shown. A movie showing the 
effect of NOC-5 on the Ca
2+ waves triggered by uncaging IP3 in an 
SMC is shown in Video 3.
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Ca
2+ store was depleted by NO or that NO may inhibit 
Ca
2+ release by blocking RYRs. To address these issues, 
we investigated the effect of NOC-5 on caffeine-induced 
Ca
2+ release that represents Ca
2+ release via the RYR. 
Caffeine triggered a biphasic transient increase in Ca
2+ 
that was accompanied by a transient airway contrac-
tion (Fig. 5 C). NOC-5 had no effect on this caffeine-
induced  Ca
2+  signaling  and  contraction,  suggesting 
that NOC-5 did not block release of Ca
2+ through the 
RYR. In addition, the ability of caffeine to stimulate a 
similar Ca
2+ response after exposure to and removal of 
NOC-5 suggests that the intracellular Ca
2+ stores are 
not altered by NO.
Effect of NO on Ca
2+ sensitivity
A second major mechanism regulating the contractil-
ity of airway SMCs is the sensitivity of the contractile 
apparatus to Ca
2+ or “Ca
2+ sensitivity” (Somlyo and 
Somlyo, 2003). To investigate if NO relaxed airway 
SMCs by reducing their Ca
2+ sensitivity, we compared 
Ca
2+ signaling and airway relaxation induced by NOC-5 
or 8pCPT-cGMP before (normal) and after Ca
2+ per-
meabilization  of  lung  slices  by  the  treatment  with   
caffeine and ryanodine (Fig. 6). This Ca
2+ permeabili-
zation protocol (see Materials and methods and Bai 
and Sanderson, 2006b) is based on the combined abil-
ity of caffeine to activate and ryanodine to irreversibly 
lock RYRs in an open state. As a result, the internal 
Ca
2+ stores empty and activate store-operated channels 
to increase the permeability of the plasma membrane 
to Ca
2+.
The effect of NOC-5 on 5-HT–induced Ca
2+ signaling 
before  and  after  Ca
2+  permeabilization  with  caffeine 
and ryanodine is shown in Fig. 6 A. As reported earlier 
here, 5-HT stimulated and NOC-5 inhibited Ca
2+ oscilla-
tions in the normal SMCs. This change in the Ca
2+ 
signaling of the SMCs correlated with the expected in-
crease and decrease in airway contraction (Fig. 6 B). 
After Ca
2+ permeabilization, the [Ca
2+]i of the same air-
way SMCs was elevated by 1.3 mM of extracellular Ca
2+ 
(in sHBSS) and remained constant regardless of the sub-
sequent expose to either 5-HT and NOC-5 (Fig. 6 A). 
This result confirms our previous results showing no 
changes in [Ca
2+]i in response to stimulation with other 
agonists (methacholine and ISO) and forskolin in Ca
2+-
permeabilized lung slices (Bai and Sanderson, 2006b; 
Perez-Zoghbi and Sanderson, 2007).
Before continuing to address our current results, it is 
extremely important to understand a specific behavior 
of mouse airways. Regardless of the fact that the [Ca
2+]i 
is elevated in Ca
2+-permeabilized mouse SMCs (Fig. 6 A), 
the mouse airways are, as observed here, almost com-
pletely relaxed (Fig. 6, B and C) in the absence of a con-
tractile agonist. This result, although counterintuitive, 
is consistently observed and has been extensively inves-
tigated in our previous work (Bai and Sanderson, 2006b; 
Figure 6.  The effect of NOC-5 on Ca
2+ sensitivity of airway SMCs. 
(A) The effect of 10 µM NOC-5 on Ca
2+ signaling induced by 
0.1 µM 5-HT in the same SMC before (Normal) and after Ca
2+ 
permeabilization with 20 mM caffeine and 50 µM ryanodine in 
sHBSS  ([Ca
2+]  =  1.3  mM).  Before  Ca
2+  permeabilization,  Ca
2+  
oscillations  were  induced  by  5-HT  and  inhibited  by  NOC-5.   
After Ca
2+ permeabilization, [Ca
2+]i was constantly elevated, and 
neither  5-HT  nor  NOC-5  induced  further  changes  in  [Ca
2+]i.   
(B and C) The response of airways contracted with 0.1 µM 5-HT 
to (B) 10 µM NOC-5 or (C) 10 µM 8pCPT-cGMP in lung slices before 
and after Ca
2+ permeabilization. Both NOC-5 and 8pCPT-cGMP 
relaxed airways before Ca
2+ permeabilization, but neither had 
much effect on airways after Ca
2+ permeabilization. Contraction 
data are representative of at least seven different slices from three 
mice. Ca
2+ data are representative of three different slices from 
one mouse.256 NO-induced relaxation and Ca
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posure  to  10  µM  NOC-5  or  10  µM  8pCPT-cGMP   
had very little effect in terms of relaxation in Ca
2+- 
permeabilized  airways  (Fig.  6,  B  and  C;  4.4  ±  1.1%,   
n = 6; 6.3 ± 3.2%, n = 3, respectively). The lack of a   
contractile response to caffeine at the end of the ex-
periment indicated that the SMCs remained permea-
bilized to Ca
2+, and the Ca
2+ stores were empty (Fig. 6, 
B and C). However, if the NOC-5 concentration was 
more than doubled to 25 and 50 µM, some airway relax-
ation  was  observed  (10.8  ±  2.4%  and  10.9  ±  5.6%,   
respectively; n = 3). Similarly, in Ca
2+-permeabilized   
airways, the relaxation induced by 25 µM NOC-5 in the 
presence of 10 µM ZAP or 1 µM vardenafil (27.7 ± 5.7 
and 23.0 ± 4.2%, respectively; n = 3) was appreciable,   
although small as compared with the relaxation ob-
served in normal airways. ZAP alone had little effect   
on the airway relaxation in Ca
2+-permeabilized airways   
(5.2 ± 0.5%; n = 3). These results suggest that NO and 
cGMP at concentrations shown to relax airways do not 
exercise their action via significant changes in SMC   
Ca
2+ sensitivity.
Changes in Ca
2+ sensitivity induced by  
cAMP-elevating agonists
To confirm the ineffectiveness of NO/cGMP to induce 
airway relaxation via a decrease in Ca
2+ sensitivity, we ex-
amined and compared the effect of two cAMP-elevating 
agents—ISO, a 2 adrenergic receptor agonist, and 
forskolin, an activator of adenylyl cyclase—on 5-HT–
contracted airways in normal and Ca
2+-permeabilized 
slices (Fig. 7). Like NO-induced airway relaxation, the 
relaxation induced by ISO in normal slices was biphasic 
(Fig. 7 A); a fast peak relaxation (53 ± 7.1%; n = 6) was 
followed by recontraction to a lower sustained relax-
ation level (23 ± 4.1%), and the removal of ISO resulted 
in a fast airway recontraction to reach the contraction 
level before ISO exposure. By comparison, forskolin in-
duced a higher and sustained (73.6 ± 4.8%; n = 4) air-
way relaxation than ISO and NOC-5. These results are 
consistent with our previous results that demonstrated 
that ISO, forskolin, and cAMP slowed SMC Ca
2+ oscilla-
tions, and the idea that ISO and forskolin stimulate syn-
thesis of cAMP to induce airway relaxation (Bai and 
Sanderson, 2006a). The recontraction after ISO expo-
sure is believed to result from a decrease in cAMP 
concentration because of a combination of receptor 
desensitization and PDE-4 activity.
However, in Ca
2+-permeabilized slices, airway relax-
ation induced by the cAMP agonists was significantly 
larger (44.9 ± 6.9%; n = 4 for forskolin) than the relax-
ation induced by NOC-5 and the cGMP analogues. These 
results demonstrate that Ca
2+-permeabilized SMCs show 
a substantial decrease in Ca
2+ sensitivity in response to   
cAMP analogues, which, in turn, emphasizes the inabil-
ity of NO/cGMP to induce a similar action to bring about 
airway relaxation.
Perez-Zoghbi and Sanderson, 2007; Wang et al., 2008). 
Our hypothesis explaining this behavior is that the 
elevated [Ca
2+]i has reduced the Ca
2+ sensitivity of the 
SMCs to almost 0 because of an increase in myosin light 
chain phosphatase (MLCP) activity. This MLCP activity 
counteracts the predicted increased myosin light chain 
kinase (MLCK) activity that is stimulated by the elevated 
[Ca
2+]i (Wang et al., 2008).
Returning to the current results, the addition of the 
contractile agonist 5-HT to the Ca
2+-permeabilized slices 
invoked a contractile response that was similar to that   
of the normal airway (Fig. 6, B and C), but in this case, 
it occurred without any change in [Ca
2+]i (Fig. 6 A). 
The implication of this result is that 5-HT has substan-
tially increased the Ca
2+ sensitivity of airway SMCs to 
bring about contraction. However, the subsequent ex-
Figure 7.  The effect of ISO and forskolin on Ca
2+ sensitivity in 
airway SMCs. The relaxation of airways, contracted with 0.1 µM 
5-HT, induced by (A) 1 µM ISO or (B) 1 µM forskolin in lung 
slices before and after Ca
2+ permeabilization with 20 mM caffeine 
and 50 µM ryanodine. ISO and forskolin strongly relaxed airways 
before and after Ca
2+ permeabilization. Data are representative of 
at least three different slices from two mice.  Perez-Zoghbi et al. 257
observed that agonist-induced Ca
2+ signaling in airway 
SMCs consisted of Ca
2+ oscillations and waves that per-
sist at a sustained frequency during the presence of 
agonist (Perez and Sanderson, 2005). Importantly, the 
sustained frequency correlated with the magnitude of 
airway contraction, suggesting that airway contraction 
is partially regulated by the frequency of Ca
2+ oscilla-
tions (Sanderson et al., 2008). Here, we observed that 
NO,  as  well  as  cGMP  analogues,  decreased  the  fre-
quency of these Ca
2+ oscillations, and this was accom-
panied by airway relaxation. Furthermore, in response 
to NO, the Ca
2+ oscillations were initially abolished, 
but  resumed  with  a  steady,  but  greatly  reduced  fre-
quency. This biphasic change in the frequency of Ca
2+ 
oscillations correlates with the initially strong airway 
relaxation followed by airway recontraction to a steady 
level of reduced airway contraction. When NO was added 
in the presence of PDE-5 inhibitors, the frequency of 
Ca
2+ oscillations was reduced further (after a longer 
phase of complete inhibition), and this correlated with 
a larger airway relaxation than that observed with NO 
alone. A similar NO-induced inhibition of Ca
2+ oscilla-
tions has also been observed in isolated porcine tra-
cheal (Prakash et al., 1997) and vascular SMCs (Kasai 
et  al.,  1997).  Consequently,  our  results  support  the   
hypothesis  that  the  reduction  in  the  frequency  of   
Ca
2+ oscillations is a mechanism responsible for the 
early and late phases of the NO-induced airway relax-
ation and the more general idea that airway contrac-
tion is a function of the frequency of Ca
2+ oscillations 
(Sanderson et al., 2008).
To investigate how NO inhibited agonist-induced Ca
2+ 
oscillations, we examined the effects of NO on Ca
2+ sig-
naling triggered by the photolytic release of IP3 in single 
SMCs in the absence of agonists. Ca
2+ oscillations of 
increasing frequency are induced in airway SMCs by 
increasing  amounts  of  IP3  release  (Bai  et  al.,  2009). 
However, by reducing the exposure time, we released a 
very small amount of IP3 in the SMC that only initiated 
a Ca
2+ transient and a brief contraction. NO reversibly 
blocked this IP3-triggered Ca
2+ signaling and contrac-
tion, suggesting that NO inhibited the release of Ca
2+ 
through IP3R. Alternatively, the NO-induced inhibition 
of Ca
2+ oscillations could occur because of a decrease in 
the Ca
2+ content of intracellular stores. For example, in 
isolated tracheal SMCs, Ca
2+ release induced by caffeine 
(an agonist of the RYR) was completely inhibited by NO 
(Prakash et al., 1997). However, this result may be inter-
preted to mean that either the intracellular Ca
2+ stores 
were emptied by NO or that the RYR was inhibited by 
NO. In contrast, in our experiments, NO did not influ-
ence the magnitude of the Ca
2+ release induced by caf-
feine. This result indicates that in mouse airway SMCs, 
the capacity or content of the Ca
2+ stores was not altered 
significantly and that the RYR remained unaffected by 
NO. Collectively, these results suggest that NO, and the 
DISCUSSION
We investigated the mechanism of NO-induced SMC re-
laxation in intrapulmonary airways by studying the 
effects of NO donors on agonist-induced airway con-
traction and Ca
2+ signaling of airway SMCs in lung slices. 
In general, NO-induced SMC relaxation or other bio-
logical  responses  are  mediated  by  two  main  mecha-
nisms: (1) a cGMP-dependent mechanism in which NO 
binds to and activates sGC to generate cGMP, or (2) a 
cGMP-independent mechanism in which a functional 
alteration of protein (i.e., activation) occurs via nitro-
sylation of thiol groups (Gaston et al., 2006; Saraiva 
and Hare, 2006). Both cGMP-dependent and cGMP-
independent mechanisms have been implicated in me-
diating NO-induced vascular (Saraiva and Hare, 2006) 
and tracheal (Janssen et al., 2000; White et al., 2002) 
SMC relaxation. In addition, smooth muscle relaxation 
induced by NO has been proposed to be mediated by 
both a reduction of intracellular Ca
2+ and a decrease in 
Ca
2+  sensitivity  (Carvajal  et  al.,  2000;  Kitazawa  et  al., 
2009). Consequently, we studied here the contribution 
of these mechanisms to the relaxation of small airways.
Here, we present several experimental results suggest-
ing that airway relaxation induced by NO is a cGMP- 
and  PKG-dependent  mechanism.  First,  the  effects  of 
NO (i.e., relaxation of agonist-induced airway contrac-
tion and inhibition of agonist-induced Ca
2+ signaling) 
were quickly reversible upon the withdrawal of NO. 
This short-lived response is more compatible with the 
relatively fast antagonistic activities of PDEs and phos-
phatases, rather than the slower kinetics associated with 
the non-enzymatic breakage of covalent bonds between 
NO and thiol groups in nitrosylated proteins. Second, 
NO-induced  relaxation  was  transitory  when  NO  was 
added alone, but sustained when initiated in the pres-
ence of ZAP or vardenafil, two selective inhibitors of the 
cGMP-specific PDE-5. These results support the hypo-
thesis that NO activates the synthesis of cGMP that, in 
turn, activates PDE-5 (Carvajal et al., 2000). Increased 
activity of PDE-5 would result in cGMP degradation and 
thereby self-limit the effects of NO. The sustained relax-
ation of the airway in the presence of PDE-5 inhibitors 
is consistent with a continued elevation of cGMP. Third, 
the  effects  of  NO  on  Ca
2+  signaling  and  contraction 
were blocked by ODQ, a specific inhibitor of sGC that 
synthesizes cGMP and is activated by NO. Fourth, the 
membrane-permeable cGMP analogues, 8pCPT-cGMP 
and 8Br-cGMP, which are both selective activators of 
cGMP-dependent PKG, induced airway relaxation and 
inhibited the Ca
2+ oscillations induced by agonists. Finally, 
Rp-8-pCPT-cGMPS, a specific inhibitor of PKG activity, 
abolished NO-induced airway relaxation.
To  further  characterize  the  mechanisms  of  NO- 
induced airway relaxation, we studied the effects of 
NO on Ca
2+ signaling in airway SMCs. Previously, we 258 NO-induced relaxation and Ca
2+ signaling in airway SMCs
This inhibition results in a decrease in the frequency of 
agonist-induced Ca
2+ oscillations. Because NO appears 
to have little effect on Ca
2+ sensitivity, the decrease in 
the frequency of the Ca
2+ oscillations is predominately 
responsible for airway relaxation.
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resulting increase in cGMP, decreased the frequency of 
agonist-induced Ca
2+ oscillations by reducing the activ-
ity  of  the  IP3R.  The  molecular  mechanism  by  which 
NO/cGMP/PKG inhibited the IP3R was not investigated 
here, but an IP3R-associated cGMP kinase substrate pro-
tein called IRAG has been identified in trachea SMC 
(Schlossmann et al., 2000; Ammendola et al., 2001). 
This protein is phosphorylated by PKG, associates with 
the IP3R, and blocks IP3R activation by IP3 and Ca
2+. 
Our results with cGMP analogues that either activate or 
inactivate PKG, and that mimic or inhibit NO-induced 
effects, support the hypothesis that PKG-mediated phos-
phorylation is involved.
A  concurrent  mechanism  regulating  SMC  contrac-
tion is the Ca
2+ sensitivity of the SMC—a Ca
2+-independent 
change in SMC contraction (Somlyo and Somlyo, 2003). 
Previously, we found that agonists strongly increase Ca
2+ 
sensitivity in airways and blood vessels in lung slices (Bai 
and  Sanderson,  2006b;  Perez-Zoghbi  and  Sanderson, 
2007). NO-induced relaxation is mostly attributed to 
a decrease in Ca
2+ sensitivity in vascular SMCs (Carvajal 
et al., 2000). Here, we investigated the contribution 
of  Ca
2+  sensitivity  in  NO-induced  airway  relaxation 
and found, with Ca
2+ permeabilized slices (caffeine-
ryanodine treated), that NO and cGMP analogues did 
not substantially decrease agonist-induced Ca
2+ sensitivity. 
However, using the same experimental approach, we 
found that airway relaxation induced by ISO and for-
skolin, agents that increase cAMP, was mediated by a 
pronounced decrease in Ca
2+ sensitivity. A similar de-
crease in Ca
2+ sensitivity has also been observed with 
other cAMP-elevating agents, including albuterol (a short 
acting 2 bronchodilator) (Delmotte and Sanderson, 
2008) and 8Br-cAMP (Bai and Sanderson, 2006b). Thus, 
these results indicate that although decreased Ca
2+ 
sensitivity  contributes  to  airway  relaxation  induced 
by cAMP, this process is relatively unimportant in air-
way relaxation induced by cGMP. Because cAMP and 
cGMP appear to act via PKA and PKG, respectively, an 
implication of this difference between ISO- and NO-
induced relaxation is that airway SMC Ca
2+ sensitivity 
is regulated by a phosphorylation-specific event. In 
contrast, decreased Ca
2+ sensitivity has been reported 
to be a central mechanism for the NO-induced relax-
ation of vascular SMCs of systemic arteries (Somlyo and 
Somlyo, 2003; Kitazawa et al., 2009). These differences 
emphasize that the intracellular pathways and mecha-
nisms regulating contraction in various SMC types can 
be different.
In conclusion, our experiments indicate that NO in-
duces a transient airway SMC relaxation via activation of 
sGC to increase cGMP that, in turn, activates PDE-5 and 
PKG (Fig. 8). Activation of PDE-5 results in degradation 
of cGMP, explaining the transient nature of the NO-
  induced airway relaxation. Activation of PKG results in 
the inhibition of IP3R and Ca
2+ release from the SR. 
Figure 8.  Signaling pathway of NO-induced SMC relaxation in 
mouse small airways. Agonists, such as 5-HT, stimulate airway 
contraction by binding to their specific G protein–coupled mem-
brane receptors (5-HT2R) to stimulate the dissociation of their 
 subunit (Gq). This Gq activates phospholipase C  (PLC) 
to synthesize IP3 that, in turn, activates SR IP3Rs to release Ca
2+ 
from the SR. The resulting high [Ca
2+]i inactivates the IP3R, and 
the Ca
2+ is pumped back into the SR by the SR/ER Ca
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